However, the current study could not find any association between circulating GLP-1 and body weight changes, indicating that low FODMAP diet-mediated changes in GLP-1 levels are not solely due to changes in body weight
While the public might see these as simply generic alternatives to brand-name medications, the FDA cautioned that it does not evaluate compounded drugs for safety or effectiveness, so they may pose unknown risks to consumers
Etayash et al
Using NHANES data, Liu et al
Combining biomarker data (serum creatinine, eGFR, BUN), genetic predispositions, and clinical history creates a fuller picture for your provider
Pricing Transparency Be very clear about cost: medication (if compounded vs branded), provider fees, injection/administration fees, follow-ups, labs etc